BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas.

High expression of BYSL in gliomas promoted tumor cell growth and survival both in vitro and in vivo. These effects could be attributed to the association of BYSL with RIOK2 and mTOR, and the subsequent activation of AKT signaling.